Taysha Gene Therapies, Inc. · NASDAQ:TSHA
Stalfort John A III received 21,335 Taysha Gene Therapies, Inc. shares as an award (Form 4)
Traded Jun 1, 2026 · Filed Jun 2, 2026
On Jun 1, 2026, Stalfort John A III (Director) received 21,335 Taysha Gene Therapies, Inc. shares as an award, leaving 1,176,559 shares. Filed Jun 2, 2026 (Form 4).
- Awarded
- 21,335 shares
- Holding after
- 1,176,559 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Award | 21,335 | 1,176,559 | Direct |
Source
Related
- Taysha Gene Therapies, Inc.
- Stalfort John A III
- Taysha Gene Therapies, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Morgan Stanley · Aug 13, 2026
- Form 4 · Nagendran Sukumar · Jul 10, 2026
- Form 4 · Donenberg Phillip B. · Jun 2, 2026
- Form 4 · Long Alison S · Jun 2, 2026